Anika Therapeutics, Inc.
ANIK
$15.03
$0.000.00%
| Weiss Ratings | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.29 | |||
| Price History | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.78% | |||
| 30-Day Total Return | -15.85% | |||
| 60-Day Total Return | -8.69% | |||
| 90-Day Total Return | -12.87% | |||
| Year to Date Total Return | -7.28% | |||
| 1-Year Total Return | -41.52% | |||
| 2-Year Total Return | -47.34% | |||
| 3-Year Total Return | -42.39% | |||
| 5-Year Total Return | -47.32% | |||
| 52-Week High % Change | -48.10% | |||
| 52-Week Low % Change | 1.07% | |||
| Price | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $29.12 | |||
| 52-Week Low Price | $14.95 | |||
| 52-Week Low Price (Date) | Mar 13, 2025 | |||
| 52-Week High Price (Date) | Jul 18, 2024 | |||
| Valuation | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 214.20M | |||
| Enterprise Value | 184.50M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.85 | |||
| Earnings Per Share Growth | -31.85% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.46 | |||
| Price/Book (Q) | 1.41 | |||
| Enterprise Value/Revenue (TTM) | 1.22 | |||
| Price | $15.03 | |||
| Enterprise Value/EBITDA (TTM) | -7.11 | |||
| Enterprise Value/EBIT | -5.36 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 14.62M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 781 457 9000 | |||
| Address | 32 Wiggins Avenue Bedford, MA 01730 | |||
| Website | www.anika.com | |||
| Country | United States | |||
| Year Founded | 1983 | |||
| Profitability | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -22.69% | |||
| Profit Margin | -37.14% | |||
| Management Effectiveness | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -9.10% | |||
| Return on Equity | -- | |||
| Income Statement | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 151.80M | |||
| Total Revenue (TTM) | 151.80M | |||
| Revenue Per Share | $10.38 | |||
| Gross Profit (TTM) | 71.64M | |||
| EBITDA (TTM) | -25.95M | |||
| EBIT (TTM) | -34.45M | |||
| Net Income (TTM) | -56.39M | |||
| Net Income Avl. to Common (TTM) | -56.39M | |||
| Total Revenue Growth (Q YOY) | 1,155.61% | |||
| Earnings Growth (Q YOY) | -115.32% | |||
| EPS Diluted (TTM) | -3.85 | |||
| EPS Diluted Growth (Q YOY) | 65.11% | |||
| Balance Sheet | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 55.63M | |||
| Cash Per Share (Q) | $3.80 | |||
| Total Current Assets (Q) | 113.65M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 153.99M | |||
| Current Ratio (Q) | 4.877 | |||
| Book Value Per Share (Q) | $10.68 | |||
| Total Assets (Q) | 202.74M | |||
| Total Current Liabilities (Q) | 23.31M | |||
| Total Debt (Q) | 25.93M | |||
| Total Liabilities (Q) | 48.75M | |||
| Total Common Equity (Q) | 153.99M | |||
| Cash Flow | ANIK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -7.03M | |||
| Cash from Financing (TTM) | -7.38M | |||
| Net Change in Cash (TTM) | -10.50M | |||
| Levered Free Cash Flow (TTM) | -330.30K | |||
| Cash from Operations (TTM) | 3.82M | |||
